Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
36.79
-0.42 (-1.13%)
Aug 11, 2026, 3:00 PM CST
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 24.92 billion as of August 10, 2026. Its market cap has decreased by -6.77% in one year.
Market Cap
24.92B
Enterprise Value
23.21B
Revenue
4.98B
Ranking
n/a
PE Ratio
13.16
Stock Price
36.79
ChartMarket Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 24.92B, an increase of 260.42%. That is a compound annual growth rate of 5.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 24.92B | -19.02% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shijiazhuang Yiling Pharmaceutical | 28.22B |
| Zhejiang Huahai Pharmaceutical | 27.11B |
| Apeloa Pharmaceutical Co.,Ltd | 26.18B |
| Dizal (Jiangsu) Pharmaceutical | 25.98B |
| Livzon Pharmaceutical Group | 24.91B |
| Hubei Jumpcan Pharmaceutical | 23.86B |
| Guangdong Zhongsheng Pharmaceutical | 23.61B |
| Tasly Pharmaceutical Group | 23.35B |